TVGN Semper Paratus Acquisition | $1.22
+1.3% | 6/18/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $10.00 | Low | View details for D. Boral Capital rating of Semper Paratus Acquisition (NASDAQ:TVGN) on 6/18/2025 |
FBLG FibroBiologics | $0.73
+1.8% | 6/17/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $16.00 | High | View details for D. Boral Capital rating of FibroBiologics (NASDAQ:FBLG) on 6/17/2025 |
GOVX GeoVax Labs | $0.95
+2.2% | 6/16/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 | High | View details for D. Boral Capital rating of GeoVax Labs (NASDAQ:GOVX) on 6/16/2025 |
BMEA Biomea Fusion | $1.80
-6.0% | 6/13/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $16.00 | High | View details for D. Boral Capital rating of Biomea Fusion (NASDAQ:BMEA) on 6/13/2025 |
QNCX Quince Therapeutics | $1.32
-2.9% | 6/13/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $4.00 | High | View details for D. Boral Capital rating of Quince Therapeutics (NASDAQ:QNCX) on 6/13/2025 |
URGN Urogen Pharma | $14.85
-0.2% | 6/12/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $25.00 | High | View details for D. Boral Capital rating of Urogen Pharma (NASDAQ:URGN) on 6/12/2025 |
HOTH Hoth Therapeutics | $1.26
-6.0% | 6/12/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $5.00 | High | View details for D. Boral Capital rating of Hoth Therapeutics (NASDAQ:HOTH) on 6/12/2025 |
ADUR Aduro Clean Technologies | $10.92
+9.9% | 6/11/2025 | Target Lowered by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $50.00 -> $48.00 | Medium | View details for D. Boral Capital rating of Aduro Clean Technologies (NASDAQ:ADUR) on 6/11/2025 |
CRVO CervoMed | $6.77
-3.1% | 6/11/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $10.00 | High | View details for D. Boral Capital rating of CervoMed (NASDAQ:CRVO) on 6/11/2025 |
ANIX Anixa Biosciences | $3.42
-3.7% | 6/10/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $10.00 | Medium | View details for D. Boral Capital rating of Anixa Biosciences (NASDAQ:ANIX) on 6/10/2025 |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. |
TVGN Semper Paratus Acquisition | $1.22
+1.3% | 6/10/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $10.00 | High | View details for D. Boral Capital rating of Semper Paratus Acquisition (NASDAQ:TVGN) on 6/10/2025 |
MDCX Medicus Pharma | $2.65
+2.7% | 6/9/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $27.00 | High | View details for D. Boral Capital rating of Medicus Pharma (NASDAQ:MDCX) on 6/9/2025 |
HUMA Humacyte | $2.33
-1.5% | 6/9/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $25.00 | Low | View details for D. Boral Capital rating of Humacyte (NASDAQ:HUMA) on 6/9/2025 |
CTXR Citius Pharmaceuticals | $0.96
+4.9% | 6/9/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 | High | View details for D. Boral Capital rating of Citius Pharmaceuticals (NASDAQ:CTXR) on 6/9/2025 |
OSTX OS Therapies | $1.85
+1.4% | 6/9/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $20.00 | High | View details for D. Boral Capital rating of OS Therapies (NYSE:OSTX) on 6/9/2025 |
RCEL Avita Medical | $5.16
-1.7% | 6/6/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $19.00 | High | View details for D. Boral Capital rating of Avita Medical (NASDAQ:RCEL) on 6/6/2025 |
NNOX Nano-X Imaging | $4.98
-1.5% | 6/6/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $10.00 | High | View details for D. Boral Capital rating of Nano-X Imaging (NASDAQ:NNOX) on 6/6/2025 |
NRXP NRx Pharmaceuticals | $3.22
-0.3% | 6/6/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $31.00 | High | View details for D. Boral Capital rating of NRx Pharmaceuticals (NASDAQ:NRXP) on 6/6/2025 |
IMUX Immunic | $0.75
+0.3% | 6/5/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $10.00 | High | View details for D. Boral Capital rating of Immunic (NASDAQ:IMUX) on 6/5/2025 |
KAPA Kairos Pharma | $0.66
+7.0% | 6/4/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 | N/A | View details for D. Boral Capital rating of Kairos Pharma (NYSEAMERICAN:KAPA) on 6/4/2025 |
QNCX Quince Therapeutics | $1.32
-2.9% | 6/4/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $4.00 | Medium | View details for D. Boral Capital rating of Quince Therapeutics (NASDAQ:QNCX) on 6/4/2025 |
RVPH Reviva Pharmaceuticals | $0.68
+1.2% | 6/3/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $3.00 | Low | View details for D. Boral Capital rating of Reviva Pharmaceuticals (NASDAQ:RVPH) on 6/3/2025 |
IBRX ImmunityBio | $2.87
+0.9% | 6/3/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $30.00 | Low | View details for D. Boral Capital rating of ImmunityBio (NASDAQ:IBRX) on 6/3/2025 |
MSAI MultiSensor AI | $0.69
-1.6% | 6/3/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $2.50 | Low | View details for D. Boral Capital rating of MultiSensor AI (NASDAQ:MSAI) on 6/3/2025 |
TRVI Trevi Therapeutics | $6.01
-1.1% | 6/2/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $21.00 | High | View details for D. Boral Capital rating of Trevi Therapeutics (NASDAQ:TRVI) on 6/2/2025 |
IMUX Immunic | $0.75
+0.3% | 5/29/2025 | Target Lowered by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $17.00 -> $10.00 | High | View details for D. Boral Capital rating of Immunic (NASDAQ:IMUX) on 5/29/2025 |
MDCX Medicus Pharma | $2.65
+2.7% | 5/29/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $27.00 | High | View details for D. Boral Capital rating of Medicus Pharma (NASDAQ:MDCX) on 5/29/2025 |
ESLA Estrella Immunopharma | $0.91
-2.2% | 5/29/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $16.00 | High | View details for D. Boral Capital rating of Estrella Immunopharma (NASDAQ:ESLA) on 5/29/2025 |
ANIX Anixa Biosciences | $3.42
-3.7% | 5/29/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $10.00 | Medium | View details for D. Boral Capital rating of Anixa Biosciences (NASDAQ:ANIX) on 5/29/2025 |
CLGN CollPlant Biotechnologies | $1.49
-0.7% | 5/28/2025 | Target Lowered by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $14.00 -> $12.00 | High | View details for D. Boral Capital rating of CollPlant Biotechnologies (NASDAQ:CLGN) on 5/28/2025 |
IBRX ImmunityBio | $2.87
+0.9% | 5/28/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $30.00 | Medium | View details for D. Boral Capital rating of ImmunityBio (NASDAQ:IBRX) on 5/28/2025 |
TVGN Semper Paratus Acquisition | $1.22
+1.3% | 5/27/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $10.00 | High | View details for D. Boral Capital rating of Semper Paratus Acquisition (NASDAQ:TVGN) on 5/27/2025 |
NNOX Nano-X Imaging | $4.98
-1.5% | 5/23/2025 | Target Lowered by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $15.00 -> $10.00 | Low | View details for D. Boral Capital rating of Nano-X Imaging (NASDAQ:NNOX) on 5/23/2025 |
MDCX Medicus Pharma | $2.65
+2.7% | 5/22/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $27.00 -> $27.00 | High | View details for D. Boral Capital rating of Medicus Pharma (NASDAQ:MDCX) on 5/22/2025 |
MVIS Microvision | $1.19
-5.2% | 5/21/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $2.50 -> $2.50 | Medium | View details for D. Boral Capital rating of Microvision (NASDAQ:MVIS) on 5/21/2025 |
RVPH Reviva Pharmaceuticals | $0.68
+1.2% | 5/20/2025 | Target Lowered by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $8.00 -> $3.00 | High | View details for D. Boral Capital rating of Reviva Pharmaceuticals (NASDAQ:RVPH) on 5/20/2025 |
PED PEDEVCO | $0.74
-0.8% | 5/20/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $1.50 -> $1.50 | Low | View details for D. Boral Capital rating of PEDEVCO (NYSE:PED) on 5/20/2025 |
IMNN Imunon | $1.01
+0.5% | 5/19/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Hold | | Low | View details for D. Boral Capital rating of Imunon (NASDAQ:IMNN) on 5/19/2025 |
IVVD Invivyd | $0.74
-0.9% | 5/16/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | Medium | View details for D. Boral Capital rating of Invivyd (NASDAQ:IVVD) on 5/16/2025 |
NRXP NRx Pharmaceuticals | $3.22
-0.3% | 5/16/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $31.00 -> $31.00 | Low | View details for D. Boral Capital rating of NRx Pharmaceuticals (NASDAQ:NRXP) on 5/16/2025 |
Why the Pentagon has its eye on Utah... (Ad) There's a strange bidding war underway in Utah...
Smack in the middle of Utah's Black Desert...The U.S. government is holding record land auctions. Why? Because it turns out America has access to a powerful new form of energy – not gas, oil, or uranium – that's buried deep beneath U.S. soil. This abundant new power source is so plentiful... the U.S. Department of Energy says it could fuel the entire U.S. economy uninterrupted for the next 2 million years. If not longer. We name the ONE company at the heart of this research here – click for details. |
HOVR New Horizon Aircraft | $2.30
+0.7% | 5/16/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $2.00 -> $2.00 | High | View details for D. Boral Capital rating of New Horizon Aircraft (NASDAQ:HOVR) on 5/16/2025 |
CTXR Citius Pharmaceuticals | $0.96
+4.9% | 5/15/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | Low | View details for D. Boral Capital rating of Citius Pharmaceuticals (NASDAQ:CTXR) on 5/15/2025 |
BMEA Biomea Fusion | $1.80
-6.0% | 5/15/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $16.00 -> $16.00 | Medium | View details for D. Boral Capital rating of Biomea Fusion (NASDAQ:BMEA) on 5/15/2025 |
FBLG FibroBiologics | $0.73
+1.8% | 5/15/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $16.00 -> $16.00 | High | View details for D. Boral Capital rating of FibroBiologics (NASDAQ:FBLG) on 5/15/2025 |
CTSO Cytosorbents | $1.20
+3.0% | 5/15/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $10.00 -> $10.00 | High | View details for D. Boral Capital rating of Cytosorbents (NASDAQ:CTSO) on 5/15/2025 |
OSTX OS Therapies | $1.85
+1.4% | 5/15/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $20.00 -> $20.00 | High | View details for D. Boral Capital rating of OS Therapies (NYSE:OSTX) on 5/15/2025 |
HUMA Humacyte | $2.33
-1.5% | 5/13/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $25.00 -> $25.00 | High | View details for D. Boral Capital rating of Humacyte (NASDAQ:HUMA) on 5/13/2025 |
IMNN Imunon | $1.01
+0.5% | 5/13/2025 | Target Lowered by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $29.00 -> $17.00 | High | View details for D. Boral Capital rating of Imunon (NASDAQ:IMNN) on 5/13/2025 |
CRVO CervoMed | $6.77
-3.1% | 5/13/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $10.00 -> $10.00 | High | View details for D. Boral Capital rating of CervoMed (NASDAQ:CRVO) on 5/13/2025 |
NRSN NeuroSense Therapeutics | $2.37
-3.3% | 5/12/2025 | Initiated by | D. Boral Capital | Analyst Jason Kolbert | Buy | $14.00 | High | View details for D. Boral Capital rating of NeuroSense Therapeutics (NASDAQ:NRSN) on 5/12/2025 |
MVIS Microvision | $1.19
-5.2% | 5/13/2025 | Target Lowered by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $3.00 -> $2.50 | High | View details for D. Boral Capital rating of Microvision (NASDAQ:MVIS) on 5/13/2025 |
USEG U.S. Energy | $1.81
-9.1% | 5/13/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $3.50 -> $3.50 | High | View details for D. Boral Capital rating of U.S. Energy (NASDAQ:USEG) on 5/13/2025 |
OMER Omeros | $3.16
-2.0% | 5/13/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $36.00 -> $36.00 | High | View details for D. Boral Capital rating of Omeros (NASDAQ:OMER) on 5/13/2025 |
NOTE FiscalNote | $0.56
+0.8% | 5/13/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $3.75 -> $3.75 | High | View details for D. Boral Capital rating of FiscalNote (NYSE:NOTE) on 5/13/2025 |
TVGN Semper Paratus Acquisition | $1.22
+1.3% | 5/12/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $10.00 -> $10.00 | High | View details for D. Boral Capital rating of Semper Paratus Acquisition (NASDAQ:TVGN) on 5/12/2025 |
UAMY United States Antimony | $2.88
-0.9% | 5/12/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $5.00 -> $5.00 | High | View details for D. Boral Capital rating of United States Antimony (NYSE:UAMY) on 5/12/2025 |
MDCX Medicus Pharma | $2.65
+2.7% | 5/12/2025 | Target Raised by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $14.00 -> $27.00 | High | View details for D. Boral Capital rating of Medicus Pharma (NASDAQ:MDCX) on 5/12/2025 |
IBRX ImmunityBio | $2.87
+0.9% | 5/12/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $30.00 -> $30.00 | High | View details for D. Boral Capital rating of ImmunityBio (NASDAQ:IBRX) on 5/12/2025 |
CLNN Clene | $4.37
| 5/8/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $23.00 -> $23.00 | High | View details for D. Boral Capital rating of Clene (NASDAQ:CLNN) on 5/8/2025 |
CNTX Context Therapeutics | $0.59
+5.4% | 5/8/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | Low | View details for D. Boral Capital rating of Context Therapeutics (NASDAQ:CNTX) on 5/8/2025 |
URGN Urogen Pharma | $14.85
-0.2% | 5/8/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $25.00 -> $25.00 | High | View details for D. Boral Capital rating of Urogen Pharma (NASDAQ:URGN) on 5/8/2025 |
CXDO Crexendo | $5.38
+1.6% | 5/7/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $10.00 -> $10.00 | High | View details for D. Boral Capital rating of Crexendo (NASDAQ:CXDO) on 5/7/2025 |
IMNN Imunon | $1.01
+0.5% | 5/7/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $29.00 -> $29.00 | High | View details for D. Boral Capital rating of Imunon (NASDAQ:IMNN) on 5/7/2025 |
OMER Omeros | $3.16
-2.0% | 5/7/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $36.00 -> $36.00 | Low | View details for D. Boral Capital rating of Omeros (NASDAQ:OMER) on 5/7/2025 |
CRMD CorMedix | $13.52
-0.5% | 5/6/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $15.00 -> $15.00 | High | View details for D. Boral Capital rating of CorMedix (NASDAQ:CRMD) on 5/6/2025 |
BMEA Biomea Fusion | $1.80
-6.0% | 5/6/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $16.00 -> $16.00 | High | View details for D. Boral Capital rating of Biomea Fusion (NASDAQ:BMEA) on 5/6/2025 |
CTSO Cytosorbents | $1.20
+3.0% | 5/2/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $10.00 -> $10.00 | High | View details for D. Boral Capital rating of Cytosorbents (NASDAQ:CTSO) on 5/2/2025 |
GOVX GeoVax Labs | $0.95
+2.2% | 5/2/2025 | Target Lowered by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $14.00 -> $9.00 | Medium | View details for D. Boral Capital rating of GeoVax Labs (NASDAQ:GOVX) on 5/2/2025 |
TTI Tetra Technologies | $3.72
-0.7% | 5/1/2025 | Target Lowered by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $5.50 -> $4.00 | High | View details for D. Boral Capital rating of Tetra Technologies (NYSE:TTI) on 5/1/2025 |
LUNG Pulmonx | $2.74
-0.4% | 5/1/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $17.00 -> $17.00 | High | View details for D. Boral Capital rating of Pulmonx (NASDAQ:LUNG) on 5/1/2025 |
NRXP NRx Pharmaceuticals | $3.22
-0.3% | 4/30/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $31.00 -> $31.00 | High | View details for D. Boral Capital rating of NRx Pharmaceuticals (NASDAQ:NRXP) on 4/30/2025 |
IMUX Immunic | $0.75
+0.3% | 4/30/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $17.00 -> $17.00 | High | View details for D. Boral Capital rating of Immunic (NASDAQ:IMUX) on 4/30/2025 |
VNRX VolitionRx | $0.67
+0.3% | 4/30/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $5.00 -> $5.00 | High | View details for D. Boral Capital rating of VolitionRx (NYSE:VNRX) on 4/30/2025 |
GFAI Guardforce AI | $1.17
-2.8% | 4/28/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $4.50 -> $4.50 | Low | View details for D. Boral Capital rating of Guardforce AI (NASDAQ:GFAI) on 4/28/2025 |
TVGN Semper Paratus Acquisition | $1.22
+1.3% | 4/29/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $10.00 -> $10.00 | High | View details for D. Boral Capital rating of Semper Paratus Acquisition (NASDAQ:TVGN) on 4/29/2025 |
CNTX Context Therapeutics | $0.59
+5.4% | 4/29/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | Low | View details for D. Boral Capital rating of Context Therapeutics (NASDAQ:CNTX) on 4/29/2025 |
MDCX Medicus Pharma | $2.65
+2.7% | 4/28/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $14.00 -> $14.00 | High | View details for D. Boral Capital rating of Medicus Pharma (NASDAQ:MDCX) on 4/28/2025 |
CMPX Compass Therapeutics | $2.33
-2.1% | 4/28/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $32.00 -> $32.00 | Medium | View details for D. Boral Capital rating of Compass Therapeutics (NASDAQ:CMPX) on 4/28/2025 |
VERI Veritone | $1.37
-3.2% | 4/28/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $4.50 -> $4.50 | High | View details for D. Boral Capital rating of Veritone (NASDAQ:VERI) on 4/28/2025 |
URGN Urogen Pharma | $14.85
-0.2% | 4/28/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $25.00 -> $25.00 | High | View details for D. Boral Capital rating of Urogen Pharma (NASDAQ:URGN) on 4/28/2025 |
RVPH Reviva Pharmaceuticals | $0.68
+1.2% | 4/24/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $8.00 -> $8.00 | Medium | View details for D. Boral Capital rating of Reviva Pharmaceuticals (NASDAQ:RVPH) on 4/24/2025 |
IBRX ImmunityBio | $2.87
+0.9% | 4/23/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $30.00 -> $30.00 | Medium | View details for D. Boral Capital rating of ImmunityBio (NASDAQ:IBRX) on 4/23/2025 |
UAMY United States Antimony | $2.88
-0.9% | 4/23/2025 | Initiated by | D. Boral Capital | Analyst Jesse Sobelson | Buy | $5.00 | Low | View details for D. Boral Capital rating of United States Antimony (NYSE:UAMY) on 4/23/2025 |
COYA Coya Therapeutics | $5.54
+0.5% | 4/22/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $18.00 -> $18.00 | High | View details for D. Boral Capital rating of Coya Therapeutics (NASDAQ:COYA) on 4/22/2025 |
OSTX OS Therapies | $1.85
+1.4% | 4/22/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $20.00 -> $20.00 | High | View details for D. Boral Capital rating of OS Therapies (NYSE:OSTX) on 4/22/2025 |
ENLV Enlivex Therapeutics | $1.07
+2.3% | 4/21/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $13.00 -> $13.00 | Medium | View details for D. Boral Capital rating of Enlivex Therapeutics (NASDAQ:ENLV) on 4/21/2025 |
MDCX Medicus Pharma | $2.65
+2.7% | 4/21/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $14.00 -> $14.00 | N/A | View details for D. Boral Capital rating of Medicus Pharma (NASDAQ:MDCX) on 4/21/2025 |
CMPX Compass Therapeutics | $2.33
-2.1% | 4/21/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $32.00 -> $32.00 | High | View details for D. Boral Capital rating of Compass Therapeutics (NASDAQ:CMPX) on 4/21/2025 |
TVGN Semper Paratus Acquisition | $1.22
+1.3% | 4/21/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $10.00 -> $10.00 | High | View details for D. Boral Capital rating of Semper Paratus Acquisition (NASDAQ:TVGN) on 4/21/2025 |
HOVR New Horizon Aircraft | $2.30
+0.7% | 4/21/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $2.00 -> $2.00 | High | View details for D. Boral Capital rating of New Horizon Aircraft (NASDAQ:HOVR) on 4/21/2025 |
Why the Pentagon has its eye on Utah... (Ad) There's a strange bidding war underway in Utah...
Smack in the middle of Utah's Black Desert...The U.S. government is holding record land auctions. Why? Because it turns out America has access to a powerful new form of energy – not gas, oil, or uranium – that's buried deep beneath U.S. soil. This abundant new power source is so plentiful... the U.S. Department of Energy says it could fuel the entire U.S. economy uninterrupted for the next 2 million years. If not longer. We name the ONE company at the heart of this research here – click for details. |
NNOX Nano-X Imaging | $4.98
-1.5% | 4/17/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $15.00 -> $15.00 | High | View details for D. Boral Capital rating of Nano-X Imaging (NASDAQ:NNOX) on 4/17/2025 |
KAPA Kairos Pharma | $0.66
+7.0% | 4/17/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | N/A | View details for D. Boral Capital rating of Kairos Pharma (NYSEAMERICAN:KAPA) on 4/17/2025 |
ADUR Aduro Clean Technologies | $10.92
+9.9% | 4/17/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $50.00 -> $50.00 | Medium | View details for D. Boral Capital rating of Aduro Clean Technologies (NASDAQ:ADUR) on 4/17/2025 |
HOTH Hoth Therapeutics | $1.26
-6.0% | 4/15/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $5.00 -> $5.00 | Medium | View details for D. Boral Capital rating of Hoth Therapeutics (NASDAQ:HOTH) on 4/15/2025 |
IBRX ImmunityBio | $2.87
+0.9% | 4/15/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $30.00 -> $30.00 | High | View details for D. Boral Capital rating of ImmunityBio (NASDAQ:IBRX) on 4/15/2025 |
MDCX Medicus Pharma | $2.65
+2.7% | 4/14/2025 | Initiated by | D. Boral Capital | Analyst Jason Kolbert | Buy | $14.00 | High | View details for D. Boral Capital rating of Medicus Pharma (NASDAQ:MDCX) on 4/14/2025 |
SCLX Scilex | $4.73
-1.3% | 4/11/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Hold | | Medium | View details for D. Boral Capital rating of Scilex (NASDAQ:SCLX) on 4/11/2025 |
OMER Omeros | $3.16
-2.0% | 4/11/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $36.00 -> $36.00 | High | View details for D. Boral Capital rating of Omeros (NASDAQ:OMER) on 4/11/2025 |
GOVX GeoVax Labs | $0.95
+2.2% | 4/10/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $18.00 -> $18.00 | Low | View details for D. Boral Capital rating of GeoVax Labs (NASDAQ:GOVX) on 4/10/2025 |
ANIX Anixa Biosciences | $3.42
-3.7% | 4/10/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $10.00 -> $10.00 | Low | View details for D. Boral Capital rating of Anixa Biosciences (NASDAQ:ANIX) on 4/10/2025 |
IMUX Immunic | $0.75
+0.3% | 4/10/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $17.00 -> $17.00 | High | View details for D. Boral Capital rating of Immunic (NASDAQ:IMUX) on 4/10/2025 |
RCEL Avita Medical | $5.16
-1.7% | 4/10/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $22.00 -> $22.00 | Low | View details for D. Boral Capital rating of Avita Medical (NASDAQ:RCEL) on 4/10/2025 |
CNTX Context Therapeutics | $0.59
+5.4% | 4/9/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | Low | View details for D. Boral Capital rating of Context Therapeutics (NASDAQ:CNTX) on 4/9/2025 |
MNOV MediciNova | $1.28
+0.4% | 4/9/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | Low | View details for D. Boral Capital rating of MediciNova (NASDAQ:MNOV) on 4/9/2025 |
IBRX ImmunityBio | $2.87
+0.9% | 4/9/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $30.00 -> $30.00 | High | View details for D. Boral Capital rating of ImmunityBio (NASDAQ:IBRX) on 4/9/2025 |
FBLG FibroBiologics | $0.73
+1.8% | 4/9/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $16.00 -> $16.00 | High | View details for D. Boral Capital rating of FibroBiologics (NASDAQ:FBLG) on 4/9/2025 |
CRMD CorMedix | $13.52
-0.5% | 4/8/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $15.00 -> $15.00 | High | View details for D. Boral Capital rating of CorMedix (NASDAQ:CRMD) on 4/8/2025 |
CLNN Clene | $4.37
| 4/8/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $23.00 -> $23.00 | High | View details for D. Boral Capital rating of Clene (NASDAQ:CLNN) on 4/8/2025 |
OSTX OS Therapies | $1.85
+1.4% | 4/7/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $20.00 -> $20.00 | High | View details for D. Boral Capital rating of OS Therapies (NYSE:OSTX) on 4/7/2025 |
AVXL Anavex Life Sciences | $8.88
-1.6% | 4/7/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $46.00 -> $46.00 | Medium | View details for D. Boral Capital rating of Anavex Life Sciences (NASDAQ:AVXL) on 4/7/2025 |
RCEL Avita Medical | $5.16
-1.7% | 4/4/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $22.00 -> $22.00 | High | View details for D. Boral Capital rating of Avita Medical (NASDAQ:RCEL) on 4/4/2025 |
ENLV Enlivex Therapeutics | $1.07
+2.3% | 4/3/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $13.00 -> $13.00 | Medium | View details for D. Boral Capital rating of Enlivex Therapeutics (NASDAQ:ENLV) on 4/3/2025 |
SCLX Scilex | $4.73
-1.3% | 4/2/2025 | Target Lowered by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $770.00 -> $630.00 | High | View details for D. Boral Capital rating of Scilex (NASDAQ:SCLX) on 4/2/2025 |
PED PEDEVCO | $0.74
-0.8% | 4/2/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $1.50 -> $1.50 | High | View details for D. Boral Capital rating of PEDEVCO (NYSE:PED) on 4/2/2025 |
MSAI MultiSensor AI | $0.69
-1.6% | 4/1/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $2.50 -> $2.50 | Medium | View details for D. Boral Capital rating of MultiSensor AI (NASDAQ:MSAI) on 4/1/2025 |
FBLG FibroBiologics | $0.73
+1.8% | 4/1/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $16.00 -> $16.00 | High | View details for D. Boral Capital rating of FibroBiologics (NASDAQ:FBLG) on 4/1/2025 |
CTSO Cytosorbents | $1.20
+3.0% | 4/1/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $10.00 -> $10.00 | Low | View details for D. Boral Capital rating of Cytosorbents (NASDAQ:CTSO) on 4/1/2025 |
CARM Carisma Therapeutics | $0.52
+3.5% | 4/1/2025 | Target Lowered by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $12.00 -> $1.00 | High | View details for D. Boral Capital rating of Carisma Therapeutics (NASDAQ:CARM) on 4/1/2025 |
RVPH Reviva Pharmaceuticals | $0.68
+1.2% | 4/1/2025 | Target Lowered by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $15.00 -> $8.00 | High | View details for D. Boral Capital rating of Reviva Pharmaceuticals (NASDAQ:RVPH) on 4/1/2025 |
IMUX Immunic | $0.75
+0.3% | 4/1/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $17.00 -> $17.00 | High | View details for D. Boral Capital rating of Immunic (NASDAQ:IMUX) on 4/1/2025 |
CMPX Compass Therapeutics | $2.33
-2.1% | 4/1/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $32.00 -> $32.00 | High | View details for D. Boral Capital rating of Compass Therapeutics (NASDAQ:CMPX) on 4/1/2025 |
OMER Omeros | $3.16
-2.0% | 4/1/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $36.00 -> $36.00 | High | View details for D. Boral Capital rating of Omeros (NASDAQ:OMER) on 4/1/2025 |
NNOX Nano-X Imaging | $4.98
-1.5% | 3/31/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $15.00 -> $15.00 | Low | View details for D. Boral Capital rating of Nano-X Imaging (NASDAQ:NNOX) on 3/31/2025 |
NRXP NRx Pharmaceuticals | $3.22
-0.3% | 3/31/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $31.00 -> $31.00 | Medium | View details for D. Boral Capital rating of NRx Pharmaceuticals (NASDAQ:NRXP) on 3/31/2025 |
KAPA Kairos Pharma | $0.66
+7.0% | 3/31/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | N/A | View details for D. Boral Capital rating of Kairos Pharma (NYSEAMERICAN:KAPA) on 3/31/2025 |
OSTX OS Therapies | $1.85
+1.4% | 3/31/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $20.00 -> $20.00 | Low | View details for D. Boral Capital rating of OS Therapies (NYSE:OSTX) on 3/31/2025 |
HOTH Hoth Therapeutics | $1.26
-6.0% | 3/31/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $5.00 -> $5.00 | Medium | View details for D. Boral Capital rating of Hoth Therapeutics (NASDAQ:HOTH) on 3/31/2025 |
IBRX ImmunityBio | $2.87
+0.9% | 3/31/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $30.00 -> $30.00 | Medium | View details for D. Boral Capital rating of ImmunityBio (NASDAQ:IBRX) on 3/31/2025 |
CKPT Checkpoint Therapeutics | $4.26
| 3/31/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $4.80 -> $4.80 | Low | View details for D. Boral Capital rating of Checkpoint Therapeutics (NASDAQ:CKPT) on 3/31/2025 |
VNRX VolitionRx | $0.67
+0.3% | 3/31/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $5.00 -> $5.00 | High | View details for D. Boral Capital rating of VolitionRx (NYSE:VNRX) on 3/31/2025 |
GOVX GeoVax Labs | $0.95
+2.2% | 3/28/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $18.00 -> $18.00 | High | View details for D. Boral Capital rating of GeoVax Labs (NASDAQ:GOVX) on 3/28/2025 |
CLGN CollPlant Biotechnologies | $1.49
-0.7% | 3/27/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $14.00 -> $14.00 | Low | View details for D. Boral Capital rating of CollPlant Biotechnologies (NASDAQ:CLGN) on 3/27/2025 |
EVTL Vertical Aerospace | $5.62
-4.6% | 3/27/2025 | Initiated by | D. Boral Capital | Analyst Jesse Sobelson | Buy | $15.00 | Medium | View details for D. Boral Capital rating of Vertical Aerospace (NYSE:EVTL) on 3/27/2025 |
COYA Coya Therapeutics | $5.54
+0.5% | 3/27/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $18.00 -> $18.00 | High | View details for D. Boral Capital rating of Coya Therapeutics (NASDAQ:COYA) on 3/27/2025 |
HUMA Humacyte | $2.33
-1.5% | 3/26/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $25.00 -> $25.00 | Medium | View details for D. Boral Capital rating of Humacyte (NASDAQ:HUMA) on 3/26/2025 |
TTI Tetra Technologies | $3.72
-0.7% | 3/26/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $5.50 -> $5.50 | High | View details for D. Boral Capital rating of Tetra Technologies (NYSE:TTI) on 3/26/2025 |
ANIX Anixa Biosciences | $3.42
-3.7% | 3/26/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $10.00 -> $10.00 | Medium | View details for D. Boral Capital rating of Anixa Biosciences (NASDAQ:ANIX) on 3/26/2025 |
CRVO CervoMed | $6.77
-3.1% | 3/26/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $10.00 -> $10.00 | High | View details for D. Boral Capital rating of CervoMed (NASDAQ:CRVO) on 3/26/2025 |
MVIS Microvision | $1.19
-5.2% | 3/25/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $3.00 -> $3.00 | High | View details for D. Boral Capital rating of Microvision (NASDAQ:MVIS) on 3/25/2025 |
CRMD CorMedix | $13.52
-0.5% | 3/25/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $15.00 -> $15.00 | High | View details for D. Boral Capital rating of CorMedix (NASDAQ:CRMD) on 3/25/2025 |
Why the Pentagon has its eye on Utah... (Ad) There's a strange bidding war underway in Utah...
Smack in the middle of Utah's Black Desert...The U.S. government is holding record land auctions. Why? Because it turns out America has access to a powerful new form of energy – not gas, oil, or uranium – that's buried deep beneath U.S. soil. This abundant new power source is so plentiful... the U.S. Department of Energy says it could fuel the entire U.S. economy uninterrupted for the next 2 million years. If not longer. We name the ONE company at the heart of this research here – click for details. |
QNCX Quince Therapeutics | $1.32
-2.9% | 3/25/2025 | Target Lowered by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $12.00 -> $4.00 | High | View details for D. Boral Capital rating of Quince Therapeutics (NASDAQ:QNCX) on 3/25/2025 |
NRXP NRx Pharmaceuticals | $3.22
-0.3% | 3/24/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $31.00 -> $31.00 | Medium | View details for D. Boral Capital rating of NRx Pharmaceuticals (NASDAQ:NRXP) on 3/24/2025 |
IMNN Imunon | $1.01
+0.5% | 3/24/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $29.00 -> $29.00 | High | View details for D. Boral Capital rating of Imunon (NASDAQ:IMNN) on 3/24/2025 |
CLNN Clene | $4.37
| 3/24/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $23.00 -> $23.00 | High | View details for D. Boral Capital rating of Clene (NASDAQ:CLNN) on 3/24/2025 |
OMER Omeros | $3.16
-2.0% | 3/21/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $36.00 -> $36.00 | High | View details for D. Boral Capital rating of Omeros (NASDAQ:OMER) on 3/21/2025 |
CNTX Context Therapeutics | $0.59
+5.4% | 3/21/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | High | View details for D. Boral Capital rating of Context Therapeutics (NASDAQ:CNTX) on 3/21/2025 |
VNRX VolitionRx | $0.67
+0.3% | 3/20/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $5.00 -> $5.00 | High | View details for D. Boral Capital rating of VolitionRx (NYSE:VNRX) on 3/20/2025 |
KAPA Kairos Pharma | $0.66
+7.0% | 3/20/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | N/A | View details for D. Boral Capital rating of Kairos Pharma (NYSEAMERICAN:KAPA) on 3/20/2025 |
IVVD Invivyd | $0.74
-0.9% | 3/20/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | Low | View details for D. Boral Capital rating of Invivyd (NASDAQ:IVVD) on 3/20/2025 |
TRVI Trevi Therapeutics | $6.01
-1.1% | 3/19/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $21.00 -> $21.00 | High | View details for D. Boral Capital rating of Trevi Therapeutics (NASDAQ:TRVI) on 3/19/2025 |
BMEA Biomea Fusion | $1.80
-6.0% | 3/19/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $16.00 -> $16.00 | High | View details for D. Boral Capital rating of Biomea Fusion (NASDAQ:BMEA) on 3/19/2025 |
COYA Coya Therapeutics | $5.54
+0.5% | 3/18/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $18.00 -> $18.00 | High | View details for D. Boral Capital rating of Coya Therapeutics (NASDAQ:COYA) on 3/18/2025 |
RCEL Avita Medical | $5.16
-1.7% | 3/18/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $22.00 -> $22.00 | Low | View details for D. Boral Capital rating of Avita Medical (NASDAQ:RCEL) on 3/18/2025 |
CRVO CervoMed | $6.77
-3.1% | 3/17/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $10.00 -> $10.00 | Low | View details for D. Boral Capital rating of CervoMed (NASDAQ:CRVO) on 3/17/2025 |
NRXP NRx Pharmaceuticals | $3.22
-0.3% | 3/17/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $31.00 -> $31.00 | Medium | View details for D. Boral Capital rating of NRx Pharmaceuticals (NASDAQ:NRXP) on 3/17/2025 |
VERI Veritone | $1.37
-3.2% | 3/17/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $4.50 -> $4.50 | High | View details for D. Boral Capital rating of Veritone (NASDAQ:VERI) on 3/17/2025 |
NOTE FiscalNote | $0.56
+0.8% | 3/17/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $3.75 -> $3.75 | High | View details for D. Boral Capital rating of FiscalNote (NYSE:NOTE) on 3/17/2025 |
MNOV MediciNova | $1.28
+0.4% | 3/14/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | High | View details for D. Boral Capital rating of MediciNova (NASDAQ:MNOV) on 3/14/2025 |
USEG U.S. Energy | $1.81
-9.1% | 3/13/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $3.50 -> $3.50 | High | View details for D. Boral Capital rating of U.S. Energy (NASDAQ:USEG) on 3/13/2025 |
IBRX ImmunityBio | $2.87
+0.9% | 3/13/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $30.00 -> $30.00 | Low | View details for D. Boral Capital rating of ImmunityBio (NASDAQ:IBRX) on 3/13/2025 |
PED PEDEVCO | $0.74
-0.8% | 3/13/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $1.50 -> $1.50 | Low | View details for D. Boral Capital rating of PEDEVCO (NYSE:PED) on 3/13/2025 |
CLNN Clene | $4.37
| 3/12/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $23.00 -> $23.00 | Low | View details for D. Boral Capital rating of Clene (NASDAQ:CLNN) on 3/12/2025 |
VNRX VolitionRx | $0.67
+0.3% | 3/12/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $5.00 -> $5.00 | Low | View details for D. Boral Capital rating of VolitionRx (NYSE:VNRX) on 3/12/2025 |
LCTX Lineage Cell Therapeutics | $0.88
-3.7% | 3/11/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $2.00 -> $2.00 | N/A | View details for D. Boral Capital rating of Lineage Cell Therapeutics (NYSEAMERICAN:LCTX) on 3/11/2025 |
TVGN Semper Paratus Acquisition | $1.22
+1.3% | 3/11/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $10.00 -> $10.00 | Low | View details for D. Boral Capital rating of Semper Paratus Acquisition (NASDAQ:TVGN) on 3/11/2025 |
CRVO CervoMed | $6.77
-3.1% | 3/11/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $10.00 -> $10.00 | High | View details for D. Boral Capital rating of CervoMed (NASDAQ:CRVO) on 3/11/2025 |
HOTH Hoth Therapeutics | $1.26
-6.0% | 3/10/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $5.00 -> $5.00 | Medium | View details for D. Boral Capital rating of Hoth Therapeutics (NASDAQ:HOTH) on 3/10/2025 |
URGN Urogen Pharma | $14.85
-0.2% | 3/10/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $25.00 -> $25.00 | High | View details for D. Boral Capital rating of Urogen Pharma (NASDAQ:URGN) on 3/10/2025 |
COYA Coya Therapeutics | $5.54
+0.5% | 3/10/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $15.00 -> $15.00 | High | View details for D. Boral Capital rating of Coya Therapeutics (NASDAQ:COYA) on 3/10/2025 |
CKPT Checkpoint Therapeutics | $4.26
| 3/10/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $4.80 | High | View details for D. Boral Capital rating of Checkpoint Therapeutics (NASDAQ:CKPT) on 3/10/2025 |
LUNG Pulmonx | $2.74
-0.4% | 3/10/2025 | Initiated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $17.00 -> $17.00 | Low | View details for D. Boral Capital rating of Pulmonx (NASDAQ:LUNG) on 3/10/2025 |
HUMA Humacyte | $2.33
-1.5% | 3/7/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $25.00 -> $25.00 | High | View details for D. Boral Capital rating of Humacyte (NASDAQ:HUMA) on 3/7/2025 |
TRVI Trevi Therapeutics | $6.01
-1.1% | 3/7/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $21.00 -> $21.00 | High | View details for D. Boral Capital rating of Trevi Therapeutics (NASDAQ:TRVI) on 3/7/2025 |
CXDO Crexendo | $5.38
+1.6% | 3/6/2025 | Target Raised by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $7.00 -> $10.00 | High | View details for D. Boral Capital rating of Crexendo (NASDAQ:CXDO) on 3/6/2025 |
ADUR Aduro Clean Technologies | $10.92
+9.9% | 3/6/2025 | Initiated by | D. Boral Capital | Analyst Jesse Sobelson | Buy | $50.00 | Medium | View details for D. Boral Capital rating of Aduro Clean Technologies (NASDAQ:ADUR) on 3/6/2025 |
CRMD CorMedix | $13.52
-0.5% | 3/5/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $15.00 -> $15.00 | High | View details for D. Boral Capital rating of CorMedix (NASDAQ:CRMD) on 3/5/2025 |
IVVD Invivyd | $0.74
-0.9% | 3/5/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | High | View details for D. Boral Capital rating of Invivyd (NASDAQ:IVVD) on 3/5/2025 |
HOTH Hoth Therapeutics | $1.26
-6.0% | 3/4/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $5.00 -> $5.00 | High | View details for D. Boral Capital rating of Hoth Therapeutics (NASDAQ:HOTH) on 3/4/2025 |
VNRX VolitionRx | $0.67
+0.3% | 3/4/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $5.00 -> $5.00 | Medium | View details for D. Boral Capital rating of VolitionRx (NYSE:VNRX) on 3/4/2025 |
TVGN Semper Paratus Acquisition | $1.22
+1.3% | 3/4/2025 | Initiated by | D. Boral Capital | Analyst Jason Kolbert | Buy | $10.00 | High | View details for D. Boral Capital rating of Semper Paratus Acquisition (NASDAQ:TVGN) on 3/4/2025 |
ENLV Enlivex Therapeutics | $1.07
+2.3% | 3/3/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $13.00 -> $13.00 | High | View details for D. Boral Capital rating of Enlivex Therapeutics (NASDAQ:ENLV) on 3/3/2025 |
SCLX Scilex | $4.73
-1.3% | 2/28/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $770.00 -> $770.00 | High | View details for D. Boral Capital rating of Scilex (NASDAQ:SCLX) on 2/28/2025 |
IBRX ImmunityBio | $2.87
+0.9% | 2/28/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $30.00 -> $30.00 | High | View details for D. Boral Capital rating of ImmunityBio (NASDAQ:IBRX) on 2/28/2025 |
FBLG FibroBiologics | $0.73
+1.8% | 2/27/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $16.00 -> $16.00 | Low | View details for D. Boral Capital rating of FibroBiologics (NASDAQ:FBLG) on 2/27/2025 |
IMNN Imunon | $1.01
+0.5% | 2/27/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $29.00 -> $29.00 | Medium | View details for D. Boral Capital rating of Imunon (NASDAQ:IMNN) on 2/27/2025 |
GOVX GeoVax Labs | $0.95
+2.2% | 2/27/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $18.00 -> $18.00 | Medium | View details for D. Boral Capital rating of GeoVax Labs (NASDAQ:GOVX) on 2/27/2025 |
TTI Tetra Technologies | $3.72
-0.7% | 2/27/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $5.50 -> $5.50 | Medium | View details for D. Boral Capital rating of Tetra Technologies (NYSE:TTI) on 2/27/2025 |
MSAI MultiSensor AI | $0.69
-1.6% | 2/26/2025 | Initiated by | D. Boral Capital | Analyst Jesse Sobelson | Buy | $2.50 | Low | View details for D. Boral Capital rating of MultiSensor AI (NASDAQ:MSAI) on 2/26/2025 |
IMUX Immunic | $0.75
+0.3% | 2/26/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $17.00 -> $17.00 | Medium | View details for D. Boral Capital rating of Immunic (NASDAQ:IMUX) on 2/26/2025 |
HUMA Humacyte | $2.33
-1.5% | 2/26/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $25.00 -> $25.00 | High | View details for D. Boral Capital rating of Humacyte (NASDAQ:HUMA) on 2/26/2025 |
Think NVDA’s run was epic? You ain’t seen nothin’ yet (Ad) Ask most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade.
In 2023, it surged 239%. And in 2024, it soared another 171% on the year…
But what if I told you there was a way to target those types of “peak Nvidia” profit opportunities in 24 hours or less? Click to find out what Nvidia’s CEO might reveal… and how Sykes is preparing to ride the wave. |
KAPA Kairos Pharma | $0.66
+7.0% | 2/26/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | N/A | View details for D. Boral Capital rating of Kairos Pharma (NYSEAMERICAN:KAPA) on 2/26/2025 |
NOTE FiscalNote | $0.56
+0.8% | 2/25/2025 | Target Raised by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $3.50 -> $3.75 | Low | View details for D. Boral Capital rating of FiscalNote (NYSE:NOTE) on 2/25/2025 |
NNOX Nano-X Imaging | $4.98
-1.5% | 2/25/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $23.00 -> $23.00 | High | View details for D. Boral Capital rating of Nano-X Imaging (NASDAQ:NNOX) on 2/25/2025 |
CMPX Compass Therapeutics | $2.33
-2.1% | 2/25/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $32.00 -> $32.00 | High | View details for D. Boral Capital rating of Compass Therapeutics (NASDAQ:CMPX) on 2/25/2025 |
CTSO Cytosorbents | $1.20
+3.0% | 2/25/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $10.00 -> $10.00 | Low | View details for D. Boral Capital rating of Cytosorbents (NASDAQ:CTSO) on 2/25/2025 |
CLNN Clene | $4.37
| 2/25/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $23.00 -> $23.00 | High | View details for D. Boral Capital rating of Clene (NASDAQ:CLNN) on 2/25/2025 |
TRVI Trevi Therapeutics | $6.01
-1.1% | 2/24/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $21.00 -> $21.00 | High | View details for D. Boral Capital rating of Trevi Therapeutics (NASDAQ:TRVI) on 2/24/2025 |
IVVD Invivyd | $0.74
-0.9% | 2/24/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | Medium | View details for D. Boral Capital rating of Invivyd (NASDAQ:IVVD) on 2/24/2025 |
MNOV MediciNova | $1.28
+0.4% | 2/21/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | High | View details for D. Boral Capital rating of MediciNova (NASDAQ:MNOV) on 2/21/2025 |
OMER Omeros | $3.16
-2.0% | 2/20/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $36.00 -> $36.00 | High | View details for D. Boral Capital rating of Omeros (NASDAQ:OMER) on 2/20/2025 |
IMUX Immunic | $0.75
+0.3% | 2/20/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $17.00 -> $17.00 | High | View details for D. Boral Capital rating of Immunic (NASDAQ:IMUX) on 2/20/2025 |
RCEL Avita Medical | $5.16
-1.7% | 2/20/2025 | Target Lowered by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $25.00 -> $22.00 | High | View details for D. Boral Capital rating of Avita Medical (NASDAQ:RCEL) on 2/20/2025 |
OSTX OS Therapies | $1.85
+1.4% | 2/20/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $20.00 -> $20.00 | Low | View details for D. Boral Capital rating of OS Therapies (NYSE:OSTX) on 2/20/2025 |
IMNN Imunon | $1.01
+0.5% | 2/19/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $29.00 -> $29.00 | High | View details for D. Boral Capital rating of Imunon (NASDAQ:IMNN) on 2/19/2025 |
CRVO CervoMed | $6.77
-3.1% | 2/19/2025 | Upgraded by | D. Boral Capital | Analyst Jason Kolbert | Hold -> Buy | $10.00 | High | View details for D. Boral Capital rating of CervoMed (NASDAQ:CRVO) on 2/19/2025 |
KAPA Kairos Pharma | $0.66
+7.0% | 2/18/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | N/A | View details for D. Boral Capital rating of Kairos Pharma (NYSEAMERICAN:KAPA) on 2/18/2025 |
MSAI MultiSensor AI | $0.69
-1.6% | 2/18/2025 | Initiated by | D. Boral Capital | Analyst Jesse Sobelson | Buy | $2.50 | High | View details for D. Boral Capital rating of MultiSensor AI (NASDAQ:MSAI) on 2/18/2025 |
CTXR Citius Pharmaceuticals | $0.96
+4.9% | 2/18/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | High | View details for D. Boral Capital rating of Citius Pharmaceuticals (NASDAQ:CTXR) on 2/18/2025 |
ESLA Estrella Immunopharma | $0.91
-2.2% | 2/18/2025 | Initiated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $16.00 -> $16.00 | High | View details for D. Boral Capital rating of Estrella Immunopharma (NASDAQ:ESLA) on 2/18/2025 |
URGN Urogen Pharma | $14.85
-0.2% | 2/18/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $25.00 -> $25.00 | High | View details for D. Boral Capital rating of Urogen Pharma (NASDAQ:URGN) on 2/18/2025 |
IBRX ImmunityBio | $2.87
+0.9% | 2/14/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $30.00 -> $30.00 | High | View details for D. Boral Capital rating of ImmunityBio (NASDAQ:IBRX) on 2/14/2025 |
RCEL Avita Medical | $5.16
-1.7% | 2/14/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $25.00 -> $25.00 | High | View details for D. Boral Capital rating of Avita Medical (NASDAQ:RCEL) on 2/14/2025 |
FBLG FibroBiologics | $0.73
+1.8% | 2/13/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $16.00 -> $16.00 | High | View details for D. Boral Capital rating of FibroBiologics (NASDAQ:FBLG) on 2/13/2025 |
URGN Urogen Pharma | $14.85
-0.2% | 2/12/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $25.00 -> $25.00 | Medium | View details for D. Boral Capital rating of Urogen Pharma (NASDAQ:URGN) on 2/12/2025 |
CLGN CollPlant Biotechnologies | $1.49
-0.7% | 2/12/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $14.00 -> $14.00 | High | View details for D. Boral Capital rating of CollPlant Biotechnologies (NASDAQ:CLGN) on 2/12/2025 |
KAPA Kairos Pharma | $0.66
+7.0% | 2/12/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | N/A | View details for D. Boral Capital rating of Kairos Pharma (NYSEAMERICAN:KAPA) on 2/12/2025 |
AVXL Anavex Life Sciences | $8.88
-1.6% | 2/12/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $46.00 -> $46.00 | High | View details for D. Boral Capital rating of Anavex Life Sciences (NASDAQ:AVXL) on 2/12/2025 |
LCTX Lineage Cell Therapeutics | $0.88
-3.7% | 2/11/2025 | Target Lowered by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $3.00 -> $2.00 | N/A | View details for D. Boral Capital rating of Lineage Cell Therapeutics (NYSEAMERICAN:LCTX) on 2/11/2025 |
HOTH Hoth Therapeutics | $1.26
-6.0% | 2/11/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $5.00 -> $5.00 | Low | View details for D. Boral Capital rating of Hoth Therapeutics (NASDAQ:HOTH) on 2/11/2025 |
ANVS Annovis Bio | $2.66
-1.7% | 2/10/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Hold | | High | View details for D. Boral Capital rating of Annovis Bio (NYSE:ANVS) on 2/10/2025 |
MVIS Microvision | $1.19
-5.2% | 2/10/2025 | Initiated by | D. Boral Capital | Analyst Jesse Sobelson | Buy | $3.00 | High | View details for D. Boral Capital rating of Microvision (NASDAQ:MVIS) on 2/10/2025 |
ENLV Enlivex Therapeutics | $1.07
+2.3% | 2/7/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $13.00 -> $13.00 | High | View details for D. Boral Capital rating of Enlivex Therapeutics (NASDAQ:ENLV) on 2/7/2025 |
VNRX VolitionRx | $0.67
+0.3% | 2/6/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $5.00 -> $5.00 | High | View details for D. Boral Capital rating of VolitionRx (NYSE:VNRX) on 2/6/2025 |
COYA Coya Therapeutics | $5.54
+0.5% | 2/6/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $15.00 -> $15.00 | Low | View details for D. Boral Capital rating of Coya Therapeutics (NASDAQ:COYA) on 2/6/2025 |
CLNN Clene | $4.37
| 2/6/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $23.00 -> $23.00 | Low | View details for D. Boral Capital rating of Clene (NASDAQ:CLNN) on 2/6/2025 |
QNCX Quince Therapeutics | $1.32
-2.9% | 2/5/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $12.00 -> $12.00 | High | View details for D. Boral Capital rating of Quince Therapeutics (NASDAQ:QNCX) on 2/5/2025 |
CLGN CollPlant Biotechnologies | $1.49
-0.7% | 2/4/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $14.00 -> $14.00 | High | View details for D. Boral Capital rating of CollPlant Biotechnologies (NASDAQ:CLGN) on 2/4/2025 |
IVVD Invivyd | $0.74
-0.9% | 2/3/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | High | View details for D. Boral Capital rating of Invivyd (NASDAQ:IVVD) on 2/3/2025 |
VERI Veritone | $1.37
-3.2% | 2/3/2025 | Initiated by | D. Boral Capital | Analyst Jesse Sobelson | Buy | $4.50 | High | View details for D. Boral Capital rating of Veritone (NASDAQ:VERI) on 2/3/2025 |
GOVX GeoVax Labs | $0.95
+2.2% | 1/31/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $18.00 -> $18.00 | Medium | View details for D. Boral Capital rating of GeoVax Labs (NASDAQ:GOVX) on 1/31/2025 |
OSTX OS Therapies | $1.85
+1.4% | 1/30/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $20.00 -> $20.00 | High | View details for D. Boral Capital rating of OS Therapies (NYSE:OSTX) on 1/30/2025 |
VNRX VolitionRx | $0.67
+0.3% | 1/29/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $5.00 -> $5.00 | Low | View details for D. Boral Capital rating of VolitionRx (NYSE:VNRX) on 1/29/2025 |
NRXP NRx Pharmaceuticals | $3.22
-0.3% | 1/28/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $31.00 -> $31.00 | High | View details for D. Boral Capital rating of NRx Pharmaceuticals (NASDAQ:NRXP) on 1/28/2025 |
AVXL Anavex Life Sciences | $8.88
-1.6% | 1/28/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $46.00 -> $46.00 | Medium | View details for D. Boral Capital rating of Anavex Life Sciences (NASDAQ:AVXL) on 1/28/2025 |
IBRX ImmunityBio | $2.87
+0.9% | 1/27/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $30.00 -> $30.00 | Medium | View details for D. Boral Capital rating of ImmunityBio (NASDAQ:IBRX) on 1/27/2025 |
IVVD Invivyd | $0.74
-0.9% | 1/27/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | High | View details for D. Boral Capital rating of Invivyd (NASDAQ:IVVD) on 1/27/2025 |
SCLX Scilex | $4.73
-1.3% | 1/27/2025 | Initiated by | D. Boral Capital | Analyst Jason Kolbert | Buy | $770.00 | Medium | View details for D. Boral Capital rating of Scilex (NASDAQ:SCLX) on 1/27/2025 |
IMNN Imunon | $1.01
+0.5% | 1/24/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $29.00 -> $29.00 | High | View details for D. Boral Capital rating of Imunon (NASDAQ:IMNN) on 1/24/2025 |
USEG U.S. Energy | $1.81
-9.1% | 1/24/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $3.50 -> $3.50 | Low | View details for D. Boral Capital rating of U.S. Energy (NASDAQ:USEG) on 1/24/2025 |
URGN Urogen Pharma | $14.85
-0.2% | 1/23/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $25.00 -> $25.00 | High | View details for D. Boral Capital rating of Urogen Pharma (NASDAQ:URGN) on 1/23/2025 |
KAPA Kairos Pharma | $0.66
+7.0% | 1/22/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $9.00 -> $9.00 | N/A | View details for D. Boral Capital rating of Kairos Pharma (NYSEAMERICAN:KAPA) on 1/22/2025 |
ANIX Anixa Biosciences | $3.42
-3.7% | 1/22/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $10.00 -> $10.00 | High | View details for D. Boral Capital rating of Anixa Biosciences (NASDAQ:ANIX) on 1/22/2025 |
CRMD CorMedix | $13.52
-0.5% | 1/22/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $15.00 -> $15.00 | Medium | View details for D. Boral Capital rating of CorMedix (NASDAQ:CRMD) on 1/22/2025 |
COYA Coya Therapeutics | $5.54
+0.5% | 1/21/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $15.00 -> $15.00 | Medium | View details for D. Boral Capital rating of Coya Therapeutics (NASDAQ:COYA) on 1/21/2025 |
HUMA Humacyte | $2.33
-1.5% | 1/21/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $25.00 -> $25.00 | Low | View details for D. Boral Capital rating of Humacyte (NASDAQ:HUMA) on 1/21/2025 |
RVPH Reviva Pharmaceuticals | $0.68
+1.2% | 1/21/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $15.00 -> $15.00 | High | View details for D. Boral Capital rating of Reviva Pharmaceuticals (NASDAQ:RVPH) on 1/21/2025 |
CXDO Crexendo | $5.38
+1.6% | 1/21/2025 | Initiated by | D. Boral Capital | Analyst Jesse Sobelson | Buy | $7.00 | High | View details for D. Boral Capital rating of Crexendo (NASDAQ:CXDO) on 1/21/2025 |
OMER Omeros | $3.16
-2.0% | 1/16/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $36.00 -> $36.00 | Medium | View details for D. Boral Capital rating of Omeros (NASDAQ:OMER) on 1/16/2025 |
IBRX ImmunityBio | $2.87
+0.9% | 1/16/2025 | Reiterated by | D. Boral Capital | Analyst Jason Kolbert | Buy -> Buy | $30.00 -> $30.00 | High | View details for D. Boral Capital rating of ImmunityBio (NASDAQ:IBRX) on 1/16/2025 |
NOTE FiscalNote | $0.56
+0.8% | 1/16/2025 | Reiterated by | D. Boral Capital | Analyst Jesse Sobelson | Buy -> Buy | $3.50 -> $3.50 | High | View details for D. Boral Capital rating of FiscalNote (NYSE:NOTE) on 1/16/2025 |
